MedMen Enterprises Inc (MMNFF)

MedMen Enterprises (MMNFF) Stock Price & Analysis


MMNFF Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.01 - $0.05
Previous Close$0.03
Average Volume (3M)1.66M
Market Cap
Enterprise Value-$136.77M
Total Cash (Recent Filing)$15.61M
Total Debt (Recent Filing)$318.18M
Price to Earnings (P/E)-0.3
Oct 26, 2023
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.10
Shares Outstanding1,301,683,764
10 Day Avg. Volume1,412,617
30 Day Avg. Volume1,659,105
Standard Deviation0.39
Financial Highlights & Ratios
Price to Book (P/B)0.39
Price to Sales (P/S)1.25
Price to Cash Flow (P/CF)7.90
P/FCF Ratio1.60
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-1.07
Enterprise Value/Gross Profit-2.10
Enterprise Value/Ebitda1.30
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0



Risk Analysis

Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was MedMen Enterprises Inc’s price range in the past 12 months?
MedMen Enterprises Inc lowest stock price was $0.01 and its highest was $0.05 in the past 12 months.
    What is MedMen Enterprises Inc’s market cap?
    Currently, no data Available
    When is MedMen Enterprises Inc’s upcoming earnings report date?
    MedMen Enterprises Inc’s upcoming earnings report date is Oct 26, 2023 which is in 22 days.
      How were MedMen Enterprises Inc’s earnings last quarter?
      MedMen Enterprises Inc released its earnings results on May 25, 2023. The company reported -$0.023 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.023.
        Is MedMen Enterprises Inc overvalued?
        According to Wall Street analysts MedMen Enterprises Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does MedMen Enterprises Inc pay dividends?
          MedMen Enterprises Inc does not currently pay dividends.
          What is MedMen Enterprises Inc’s EPS estimate?
          MedMen Enterprises Inc’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does MedMen Enterprises Inc have?
          MedMen Enterprises Inc has 1,391,916,900 shares outstanding.
            What happened to MedMen Enterprises Inc’s price movement after its last earnings report?
            MedMen Enterprises Inc reported an EPS of -$0.023 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
              Which hedge fund is a major shareholder of MedMen Enterprises Inc?
              Currently, no hedge funds are holding shares in MMNFF


              MedMen Enterprises Stock Smart Score

              The MedMen Enterprises stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
              Learn more about TipRanks Smart Score

              Company Description

              MedMen Enterprises Inc

              MedMen Enterprises, Inc. engages in the cultivation, production, and retailing of cannabis supply chain. It operates growing and manufacturing facilities which use agronomic technology and sustainable techniques. The company was founded by Adam Bierman and Andrew Modlin in 2010 and is headquartered in Culver City, CA.


              Forecast EPS vs Actual EPS

              Similar Stocks
              Price & Change
              Green Thumb Industries
              Cresco Labs
              Aquestive Therapeutics

              Popular Stocks

              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis